Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-α and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia
- 1 May 2002
- journal article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 35 (5), 994-998
- https://doi.org/10.1067/mva.2002.123091
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue ProtectionAnnual Review of Pharmacology and Toxicology, 2001
- Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonistsBritish Journal of Pharmacology, 2001
- Design, Synthesis, and Evaluation of Novel A2A Adenosine Receptor AgonistsJournal of Medicinal Chemistry, 2001
- A2Aadenosine receptor-mediated inhibition of renal injury and neutrophil adhesionAmerican Journal of Physiology-Renal Physiology, 2000
- Blockade of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) Protects against Ischemia-Reperfusion Injury in Muscle Flaps at Microcirculatory LevelPlastic and Reconstructive Surgery, 1999
- Spinal cord protection during aortic cross-clamping using retrograde venous perfusionThe Annals of Thoracic Surgery, 1999
- Role of A2A adenosine receptors in inflammationDrug Development Research, 1998
- A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST?British Journal of Haematology, 1995
- Southwestern Internal Medicine Conference: Endothelial Dysfunction and Vascular DiseaseThe American Journal of the Medical Sciences, 1994
- Changes in cerebrospinal fluid pressure and spinal cord perfusion pressure prior to cross-clamping of the thoracic aorta in humansJournal of Cardiothoracic and Vascular Anesthesia, 1991